{{Rsnum
|rsid=6713532
|Gene=POMC
|Chromosome=2
|position=25161964
|Orientation=plus
|GMAF=0.45
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=POMC
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 31.0 | 61.9
| HCB | 38.5 | 48.1 | 13.3
| JPT | 43.4 | 40.7 | 15.9
| YRI | 39.5 | 45.6 | 15.0
| ASW | 23.2 | 55.4 | 21.4
| CHB | 38.5 | 48.1 | 13.3
| CHD | 38.0 | 44.4 | 17.6
| GIH | 25.7 | 36.6 | 37.6
| LWK | 11.9 | 56.9 | 31.2
| MEX | 24.6 | 43.9 | 31.6
| MKK | 17.9 | 48.7 | 33.3
| TSI | 10.9 | 46.5 | 42.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=21211529
|Title=Association study of POMC variants with body composition measures and nutrient choice
}}

{{PMID Auto
|PMID=18589403
|Title=The opioid peptides enkephalin and beta-endorphin in alcohol dependence.
|OA=1
}}

{{PMID Auto
|PMID=19217079
|Title=Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies.
|OA=1
}}

{{PMID Auto
|PMID=21390334
|Title=Genetic polymorphisms in the hypothalamic pathway in relation to subsequent weight change--the DiOGenes study.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}